Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary dysmenorrhea treated with indomethacin.

J C Morrison, J C Jennings

    Southern Medical Journal
    |April 1, 1979
    PubMed
    Summary

    Indomethacin effectively treats primary dysmenorrhea by reducing prostaglandin F2alpha. This antiprostaglandin agent provided significant pain relief for most women in the study.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    'Clinicians Engagement with Research: Motivating and Impeding Factors'.

    Irish medical journal·2023
    Same author

    The role of fetal inflammatory response syndrome and fetal anemia in nonpreventable term neonatal encephalopathy.

    Journal of perinatology : official journal of the California Perinatal Association·2016
    Same author

    Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis.

    BJOG : an international journal of obstetrics and gynaecology·2014
    Same author

    Production, recovery, and purification of synnematin A and B.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Effect of synnematin B treatment of Salmonella infections in mice and chicks.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    The bactericidal action of synnematin B.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014

    Area of Science:

    • Gynecology
    • Pharmacology

    Background:

    • Primary dysmenorrhea presents a significant treatment challenge, often managed symptomatically.
    • Elevated prostaglandin F2alpha levels are implicated as a potential cause of primary dysmenorrhea.

    Purpose of the Study:

    • To evaluate the efficacy of indomethacin, an antiprostaglandin agent, in treating primary dysmenorrhea.
    • To compare the effects of indomethacin versus placebo in a randomized, double-blind study.

    Main Methods:

    • A randomized, double-blind, placebo-controlled trial involving 32 women diagnosed with primary dysmenorrhea.
    • Participants received either indomethacin or a placebo, taken three times daily for four cycles, starting two days prior to expected pain onset.

    Main Results:

    • 100% of patients receiving indomethacin experienced symptom improvement, with 11 reporting complete pain cessation.
    • Only 2 out of 16 patients in the placebo group showed significant improvement.
    • Upon switching to indomethacin post-study, the original placebo group reported substantial relief, with 12 of 16 achieving complete pain cessation.

    Conclusions:

    • Indomethacin demonstrates significant efficacy in relieving primary dysmenorrhea.
    • The incidence of side effects, primarily gastric irritation, was comparable between the indomethacin and placebo groups, suggesting a favorable safety profile.

    Related Experiment Videos